SLNOSoleno TherapeuticsSLNO info
$45.27info-4.99%24h
Global rank6558
Market cap$1.38B
Change 7d-3.95%
YTD Performance12.36%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Soleno Therapeutics (SLNO) Stock Overview

    Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

    SLNO Stock Information

    Symbol
    SLNO
    Address
    203 Redwood Shores ParkwayRedwood City, CA 94065United States
    Founded
    -
    Trading hours
    -
    Website
    https://soleno.life
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    650 213 8444

    Soleno Therapeutics (SLNO) Price Chart

    -
    Value:-

    Soleno Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $45.27
    N/A
    Market Cap
    $1.38B
    N/A
    Shares Outstanding
    30.50M
    N/A
    Employees
    25.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org